English
español
Navegación por Autor Reece, Donna
Mostrando resultados 1 a 3 de 3
Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
openAccess | | 23-mar-2023 | Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy | Raje, Noopur; Mateos, Maria Victoria; Iida, Shinsuke; Reece, Donna | artículo de revisión |
openAccess | | 2020 | Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Dimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Weisel, Katja C.; San-Miguel, Jesús; Shpilberg, Ofer; Grosicki, Sebastian; Špička, Ivan; Walter-Croneck, Adam; Magen, Hila; Mateos, Maria Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Spencer, Andrew; Oakervee, Heather; Orlowski, R. Z.; Taniwaki, Masafumi; Röllig, Christoph; Einsele, Hermann; Matsumoto, Morio; Wu, Ka Lung; Anderson, Kenneth; Jou, Ying-Ming; Ganetsky, Alex; Singhal, Anil K.; Richardson, Paul G. | artículo |
closedAccess | | 2019 | Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study | Mateos, Maria Victoria; Orlowski, R. Z.; Ocio, Enrique M. CSIC ORCID ; Rodríguez-Otero, Paula; Reece, Donna; Moreau, Philippe; Munshi, Nikhil; Avigan, David E.; Siegel, David S.; Ghori, Razi; Farooqui, Mohammed Z. H.; Marinello, Patricia; San Miguel, Jesús F. CSIC ORCID | artículo |